The ketogenic diet could improve the efficacy of curcumin and Oldenlandia diffusa extract in the treatment of gastric cancer by increasing miR340 expression and apoptosis mediated by autophagy, oxidative stress, and angiogenesis
Qiuju Xiao
Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China
Search for more papers by this authorBo Deng
Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China
Search for more papers by this authorAbolfazl Akbari
Department of Physiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran
Search for more papers by this authorCorresponding Author
Qisheng Liu
Department of Gastroenterology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China
Correspondence
Qisheng Liu, Department of Gastroenterology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437199, Hubei, China.
Email: [email protected]
Bisheng Zhu, Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437199, Hubei, China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Bisheng Zhu
Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China
Correspondence
Qisheng Liu, Department of Gastroenterology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437199, Hubei, China.
Email: [email protected]
Bisheng Zhu, Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437199, Hubei, China.
Email: [email protected]
Search for more papers by this authorQiuju Xiao
Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China
Search for more papers by this authorBo Deng
Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China
Search for more papers by this authorAbolfazl Akbari
Department of Physiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran
Search for more papers by this authorCorresponding Author
Qisheng Liu
Department of Gastroenterology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China
Correspondence
Qisheng Liu, Department of Gastroenterology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437199, Hubei, China.
Email: [email protected]
Bisheng Zhu, Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437199, Hubei, China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Bisheng Zhu
Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China
Correspondence
Qisheng Liu, Department of Gastroenterology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437199, Hubei, China.
Email: [email protected]
Bisheng Zhu, Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437199, Hubei, China.
Email: [email protected]
Search for more papers by this authorQiuju Xiao and Bo Deng are the first authors in this research and had an equal role in this research.
Qisheng Liu and Bisheng Zhu are the authors of the correspondence and had an equal role in this research.
Abstract
The pathogenesis of gastric cancer is a multistage process that involves glucose metabolism, inflammation, oxidative damage, angiogenesis, autophagy, and apoptosis. Moreover, microRNA-340 (miR340) also plays a vital role in tumorigenesis and the biology of gastric cancer as an epigenetic factor. It seems that the use of ketogenic diets (KDs) and plant extracts that have antitumor, anti-inflammatory, and antioxidant properties can be good treatment options to cure gastric cancer. The aim of this study was to investigate the role of miR-340 on pathways involved in the pathogenesis of gastric cancer and the improving effects of the KD, Oldenlandia diffusa extract (ODE), and curcumin in the animal model of gastric cancer. One hundred and ten male Wistar rats were divided into control and treatment groups. The expression of miR-340 along with genes involved in inflammation, oxidative damage, angiogenesis, and apoptosis were assessed. The results showed that the KD and different doses of curcumin and ODE in a dose-dependent behavior could induce apoptosis and the expression of the Akt/mTORC1 pathway and inhibit inflammation, oxidative damage, and angiogenesis in the gastric tissue of rats with cancer. In addition, there was no significant difference between cancer groups receiving ODE and curcumin. These results also showed that consumption of KD could significantly increase the efficacy of ODE and curcumin which may be due to increasing miR-340 expression. The results of this study suggested well that the KD along with conventional therapies in traditional medicine can be a useful solution for the prevention and treatment of gastric cancer.
Practical applications
Gastric cancer is the third leading cause of cancer death, and genetic and epigenetic factors, including miR-340, are involved in its pathogenesis. However, the use of ketogenic diets (KDs) and plant products such as curcumin and Oldenlandia diffusa extract (ODE) can play an effective role in inhibiting tumorigenesis in some cancers. Our results showed that the KD and different doses of curcumin and ODE could induce apoptosis and the expression of the Akt/mTORC1 pathway and inhibit inflammation, oxidative damage, and angiogenesis in the gastric tissue. Moreover, the KD could significantly increase the efficacy of ODE and curcumin which may be due to an increase in miR-340 expression. These findings provide novel perceptions about the mechanisms of the KD, curcumin, and ODE to cure gastric cancer. It suggested that the KD as adjunctive therapy along with conventional therapies in traditional medicine could be considered a useful solution to prevent and treat gastric cancer.
CONFLICT OF INTEREST
No potential conflict of interest was reported by the authors.
Open Research
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- Abdelwahab, M. G., Fenton, K. E., Preul, M. C., Rho, J. M., Lynch, A., Stafford, P., & Scheck, A. C. (2012). The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One, 7, e36197.
- Aebi, H. (1984). Catalase in vitro. Methods in Enzymology, 105, 121–126.
- Akbari, A., Nasiri, K., Heydari, M., Mosavat, S. H., & Iraji, A. (2017). The protective effect of hydroalcoholic extract of Zingiber officinale roscoe (ginger) on ethanol-induced reproductive toxicity in male rats. Journal of evidence-based complementary & alternative medicine, 22, 609–617.
- Allen, B. G., Bhatia, S. K., Buatti, J. M., Brandt, K. E., Lindholm, K. E., Button, A. M., Szweda, L. I., Smith, B. J., Spitz, D. R., & Fath, M. A. (2013). Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 19, 3905–3913.
- Almora-Pinedo, Y., Arroyo-Acevedo, J., Herrera-Calderon, O., Chumpitaz-Cerrate, V., Hañari-Quispe, R., Tinco-Jayo, A., Franco-Quino, C., & Figueroa-Salvador, L. (2017). Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU) induced gastric cancer in rats. Clinical and Experimental Gastroenterology, 10, 327–332.
- Aminzadeh-Gohari, S., Feichtinger, R. G., Vidali, S., Locker, F., Rutherford, T., O'donnel, M., Stöger-Kleiber, A., Mayr, J. A., Sperl, W., & Kofler, B. (2017). A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model. Oncotarget, 8, 64728–64744.
- Barati, N., Momtazi-Borojeni, A. A., Majeed, M., & Sahebkar, A. (2019). Potential therapeutic effects of curcumin in gastric cancer. Journal of Cellular Physiology, 234, 2317–2328.
- Bonofiglio, D., Giordano, C., De Amicis, F., Lanzino, M., & Andò, S. (2016). Natural products as promising antitumoral agents in breast cancer: Mechanisms of action and molecular targets. Mini Reviews in Medicinal Chemistry, 16, 596–604.
- Bowers, L. W., Rossi, E. L., O'flanagan, C. H., Degraffenried, L. A., & Hursting, S. D. (2015). The role of the insulin/IGF system in cancer: Lessons learned from clinical trials and the energy balance-cancer link. Frontiers in Endocrinology, 6, 77.
- Calibasi-Kocal, G., Pakdemirli, A., Bayrak, S., Ozupek, N. M., Sever, T., Basbinar, Y., Ellidokuz, H., & Yigitbasi, T. (2019). Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer. Journal of BUON, 24, 1482–1487.
- Catanzaro, G., Filardi, T., Sabato, C., Vacca, A., Migliaccio, S., Morano, S., & Ferretti, E. (2021). Tissue and circulating microRNAs as biomarkers of response to obesity treatment strategies. Journal of Endocrinological Investigation, 44, 1159–1174.
- Chakraborty, G., Jain, S., Kale, S., Raja, R., Kumar, S., Mishra, R., & Kundu, G. C. (2008). Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression. Molecular Medicine Reports, 1, 641–646.
- Chen, R., He, J., Tong, X., Tang, L., & Liu, M. (2016). The Hedyotis diffusa Willd.(Rubiaceae): A review on phytochemistry, pharmacology, quality control and pharmacokinetics. Molecules, 21, 710.
- Cortez, N. E., & Mackenzie, G. G. (2021). Ketogenic diets in pancreatic cancer and associated cachexia: Cellular mechanisms and clinical perspectives. Nutrients, 13, 3202.
- Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008). Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research, 14, 4491–4499.
- Dolati, S., Aghebati-Maleki, L., Ahmadi, M., Marofi, F., Babaloo, Z., Ayramloo, H., Jafarisavari, Z., Oskouei, H., Afkham, A., Younesi, V., Nouri, M., & Yousefi, M. (2018). Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial. Journal of Cellular Physiology, 233(7), 5222–5230.
- Dong, P., Konno, Y., Watari, H., Hosaka, M., Noguchi, M., & Sakuragi, N. (2014). The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer. Journal of Translational Medicine, 12, 231–240.
- Ernst, P. (1999). Review article: The role of inflammation in the pathogenesis of gastric cancer. Alimentary Pharmacology & Therapeutics, 13(Suppl 1), 13–18.
- Fang, X., Ge, K., Song, C., Ge, Y., & Zhang, J. (2018). Effects of n-3PUFAs on autophagy and inflammation of hypothalamus and body weight in mice. Biochemical and Biophysical Research Communications, 501, 927–932.
- Fernandez, S., Risolino, M., Mandia, N., Talotta, F., Soini, Y., Incoronato, M., Condorelli, G., Banfi, S., & Verde, P. (2015). miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene, 34, 3240–3250.
- Freitas, R. D. S., & Campos, M. M. (2019). Protective effects of Omega-3 fatty acids in cancer-related complications. Nutrients, 11, 945.
- Fu, S.-P., Wang, J.-F., Xue, W.-J., Liu, H.-M., Liu, B.-R., Zeng, Y.-L., Li, S.-N., Huang, B.-X., Lv, Q.-K., & Wang, W. (2015). Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms. Journal of Neuroinflammation, 12, 1–14.
- Gao, X., Li, C., Tang, Y.-L., Zhang, H., & Chan, S.-W. (2016). Effect of Hedyotis diffusa water extract on protecting human hepatocyte cells (LO2) from H2O2-induced cytotoxicity. Pharmaceutical Biology, 54, 1148–1155.
- Gu, G., Barone, I., Gelsomino, L., Giordano, C., Bonofiglio, D., Statti, G., Menichini, F., Catalano, S., & Andò, S. (2012). Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation. Journal of Cellular Physiology, 227, 3363–3372.
- Gupta, S., Zhang, D., Yi, J., & Shao, J. (2004). Anticancer activities of Oldenlandia diffusa. Journal of Herbal Pharmacotherapy, 4, 21–33.
- Han, X., Zhang, X., Wang, Q., Wang, L., & Yu, S. (2020). Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms. Biomedicine & Pharmacotherapy, 130, 110735.
- Hao, G. W., Chen, Y. S., He, D. M., Wang, H. Y., Wu, G. H., & Zhang, B. (2015). Growth of human colon cancer cells in nude mice is delayed by ketogenic diet with or without omega-3 fatty acids and medium-chain triglycerides. Asian Pacific Journal of Cancer Prevention, 16, 2061–2068.
- Hardbower, D. M., De Sablet, T., Chaturvedi, R., & Wilson, K. T. (2013). Chronic inflammation and oxidative stress: The smoking gun for helicobacter pylori-induced gastric cancer? Gut Microbes, 4, 475–481.
- Hassanalilou, T., Ghavamzadeh, S., & Khalili, L. (2019). Curcumin and gastric cancer: A review on mechanisms of action. Journal of Gastrointestinal Cancer, 50, 185–192.
- Hoffman, R. D., Li, C. Y., He, K., Wu, X., He, B. C., He, T. C., & Gao, J. L. (2020). Chinese herbal medicine and its regulatory effects on tumor related T cells. Frontiers in Pharmacology, 11, 492.
- Hopkins, B. D., Pauli, C., Du, X., Wang, D. G., Li, X., Wu, D., Amadiume, S. C., Goncalves, M. D., Hodakoski, C., Lundquist, M. R., Bareja, R., Ma, Y., Harris, E. M., Sboner, A., Beltran, H., Rubin, M. A., Mukherjee, S., & Cantley, L. C. (2018). Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature, 560, 499–503.
- Hu, P. J., Yu, J., Zeng, Z. R., Leung, W. K., Lin, H. L., Tang, B. D., Bai, A. H. C., & Sung, J. J. Y. (2004). Chemoprevention of gastric cancer by celecoxib in rats. Gut, 53, 195–200.
- Huang, Z., Li, Q., Luo, K., Zhang, Q., Geng, J., Zhou, X., Xu, Y., Qian, M., Zhang, J.-A., Ji, L., & Wu, J. (2019). miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer. Cell Death & Disease, 10, 372.
- Huang, K., Tang, Y., He, L., & Dai, Y. (2016). MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway. Oncology Reports, 35(2), 887–895.
- Huang, Z., Xu, Y., Wan, M., Zeng, X., & Wu, J. (2021). miR-340: A multifunctional role in human malignant diseases. International Journal of Biological Sciences, 17, 236–246.
- Jarrett, S. G., Milder, J. B., Liang, L. P., & Patel, M. (2008). The ketogenic diet increases mitochondrial glutathione levels. Journal of Neurochemistry, 106, 1044–1051.
- Ji, S., Fattahi, A., Raffel, N., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2017). Antioxidant effect of aqueous extract of four plants with therapeutic potential on gynecological diseases; Semen persicae, Leonurus cardiaca, Hedyotis diffusa, and Curcuma zedoaria. European Journal of Medical Research, 22, 50–58.
- Jiang, J., Wang, B., Li, J., Ye, B., Lin, S., Qian, W., Shan, L., & Efferth, T. (2017). Total coumarins of Hedyotis diffusa induces apoptosis of myelodysplastic syndrome SKM-1 cells by activation of caspases and inhibition of PI3K/Akt pathway proteins. Journal of Ethnopharmacology, 196, 253–260.
- Khodabakhshi, A., Akbari, M. E., Mirzaei, H. R., Mehrad-Majd, H., Kalamian, M., & Davoodi, S. H. (2020). Feasibility, safety, and beneficial effects of MCT-based ketogenic diet for breast cancer treatment: A randomized controlled trial study. Nutrition and Cancer, 72, 627–634.
- Kim, D. H., Park, M. H., Ha, S., Bang, E. J., Lee, Y., Lee, A. K., Lee, J., Yu, B. P., & Chung, H. Y. (2019). Anti-inflammatory action of β-hydroxybutyrate via modulation of PGC-1α and FoxO1, mimicking calorie restriction. Aging (Albany NY), 11, 1283.
- Kim, S. G., Veena, M. S., Basak, S. K., Han, E., Tajima, T., Gjertson, D. W., Starr, J., Eidelman, O., Pollard, H. B., & Srivastava, M. (2011). Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: A pilot study. Clinical Cancer Research, 17, 5953–5961.
- Klement, R. J. (2018). Fasting, fats, and physics: Combining ketogenic and radiation therapy against cancer. Complementary Medicine Research, 25, 102–113.
- Kooti, W., Servatyari, K., Behzadifar, M., Asadi-Samani, M., Sadeghi, F., Nouri, B., & Zare Marzouni, H. (2017). Effective medicinal Plant in Cancer Treatment, part 2: Review study. Journal of Evidence-Based Complementary & Alternative Medicine, 22, 982–995.
- Kumari, S., Badana, A. K., & Malla, R. (2018). Reactive oxygen species: A key constituent in cancer survival. Biomarker Insights, 13, 1177271918755391.
- Laviano, A., Rianda, S., Molfino, A., & Rossi Fanelli, F. (2013). Omega-3 fatty acids in cancer. Current Opinion in Clinical Nutrition and Metabolic Care, 16, 156–161.
- Lee, H., Lee, H. J., Bae, I. J., Kim, J. J., & Kim, S. H. (2017). Inhibition of STAT3/VEGF/CDK2 axis signaling is critically involved in the antiangiogenic and apoptotic effects of arsenic herbal mixture PROS in non-small lung cancer cells. Oncotarget, 8, 101771–101783.
- Lee, S., Shim, J. H., Gim, H., Park, H. S., & Kim, B. J. (2016). Ethanol extract of Oldenlandia diffusa–an effective chemotherapeutic for the treatment of colorectal cancer in humans:-anti-cancer effects of Oldenlandia diffusa. Journal of Pharmacopuncture, 19, 51.
- Li, H., Lai, Z., Yang, H., Peng, J., Chen, Y., & Lin, J. (2019). Hedyotis diffusa Willd. inhibits VEGF-C-mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways. Oncology Reports, 42, 1225–1236.
- Liang, Z., He, M., Fong, W., Jiang, Z., & Zhao, Z. (2008). A comparable, chemical and pharmacological analysis of the traditional Chinese medicinal herbs Oldenlandia diffusa and O. corymbosa and a new valuation of their biological potential. Phytomedicine, 15, 259–267.
- Lin, J., Wei, L., Shen, A., Cai, Q., Xu, W., Li, H., Zhan, Y., Hong, Z., & Peng, J. (2013). Hedyotis diffusa Willd extract suppresses sonic hedgehog signaling leading to the inhibition of colorectal cancer angiogenesis. International Journal of Oncology, 42, 651–656.
- Liu, H., Huang, J., Liu, H., Li, F., Peng, Q., & Liu, C. (2020). Effects of ketogenic diet containing medium-chain fatty acids on serum inflammatory factor and mTOR signaling pathway in rats. Chemical and Biological Technologies in Agriculture, 7, 27.
- Liu, W. H., Yuan, J. B., Zhang, F., & Chang, J. X. (2019). Curcumin inhibits proliferation, migration and invasion of gastric cancer cells via Wnt3a/β-catenin/EMT signaling pathway. Zhongguo Zhong Yao Za Zhi, 44, 3107–3115.
- Lu, G., & Zhang, Y. (2019). MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503. Cellular & Molecular Biology Letters, 24, 1–13.
- Lu, P.-H., Chen, M.-B., Ji, C., Li, W.-T., Wei, M.-X., & Wu, M.-H. (2016). Aqueous Oldenlandia diffusa extracts inhibits colorectal cancer cells via activating AMP-activated protein kinase signalings. Oncotarget, 7, 45889.
- Martin-Mcgill, K. J., Marson, A. G., Smith, C. T., & Jenkinson, M. D. (2017). Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): Study protocol for a randomised pilot study. Pilot and Feasibility Studies, 3, 1–11.
- McDaniel, S. S., Rensing, N. R., Thio, L. L. L., Yamada, K. A., & Wong, M. (2011). The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia, 52, e7–e11.
- Milder, J. B., Liang, L.-P., & Patel, M. (2010). Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiology of Disease, 40, 238–244.
- Mudduluru, G., George-William, J. N., Muppala, S., Asangani, I. A., Kumarswamy, R., Nelson, L. D., & Allgayer, H. (2011). Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Bioscience Reports, 31, 185–197.
- Muninggar, L., Yuliati, I., Askandar, B., & Hartono, P. (2018). Effects of curcumin on vascular endothelial growth factor expression on Rattus norvegicus cervical cancer xenograft model. Indonesian Journal of Cancer, 12, 95–101.
10.33371/ijoc.v12i3.616 Google Scholar
- Newman, J. C., & Verdin, E. (2014). β-Hydroxybutyrate: Much more than a metabolite. Diabetes Research and Clinical Practice, 106, 173–181.
- Otto, C., Kaemmerer, U., Illert, B., Muehling, B., Pfetzer, N., Wittig, R., Voelker, H. U., Thiede, A., & Coy, J. F. (2008). Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer, 8, 122.
- Poff, A. M., Ward, N., Seyfried, T. N., Arnold, P., & D'agostino, D. P. (2015). Non-toxic metabolic Management of Metastatic Cancer in VM mice: Novel combination of ketogenic diet, ketone supplementation, and hyperbaric oxygen therapy. PLoS One, 10, e0127407.
- Qian, K., Fu, D., Jiang, B., Wang, Y., Tian, F., Song, L., & Li, L. (2021). Mechanism of Hedyotis diffusa in the treatment of cervical cancer. Frontiers in Pharmacology, 12, 808144.
- Radisavljevic, Z. (2013). AKT as locus of cancer angiogenic robustness and fragility. Journal of Cellular Physiology, 228, 21–24.
- Rajabi, M., & Mousa, S. A. (2017). The role of angiogenesis in cancer treatment. Biomedicine, 5, 34.
- Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010). Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biology & Medicine, 49, 1603–1616.
- Rychahou, P. G., Kang, J., Gulhati, P., Doan, H. Q., Chen, L. A., Xiao, S.-Y., Chung, D. H., & Evers, B. M. (2008). Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proceedings of the National Academy of Sciences, 105, 20315–20320.
- Safarzadeh, E., Shotorbani, S. S., & Baradaran, B. (2014). Herbal medicine as inducers of apoptosis in cancer treatment. Advanced Pharmaceutical Bulletin, 4, 421.
- Sasaki, T., Yamashita, Y., & Kuniyasu, H. (2015). AKT plays a crucial role in gastric cancer (review). Oncology Letters, 10, 607–611.
- Scheck, A. C., Abdelwahab, M. G., Fenton, K. E., & Stafford, P. (2012). The ketogenic diet for the treatment of glioma: Insights from genetic profiling. Epilepsy Research, 100, 327–337.
- Seo, S. U., Woo, S. M., Lee, H.-S., Kim, S. H., Min, K.-J., & Kwon, T. K. (2018). mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy. Oncogene, 37, 5205–5220.
- Shabaninejad, Z., Pourhanifeh, M. H., Movahedpour, A., Mottaghi, R., Nickdasti, A., Mortezapour, E., Shafiee, A., Hajighadimi, S., Moradizarmehri, S., Sadeghian, M., Mousavi, S. M., & Mirzaei, H. (2020). Therapeutic potentials of curcumin in the treatment of glioblstoma. European Journal of Medicinal Chemistry, 188, 112040.
- Shakibaei, M., Mobasheri, A., Lueders, C., Busch, F., Shayan, P., & Goel, A. (2013). Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PLoS One, 8, e57218.
- Shang, S., Wang, L., Zhang, Y., Lu, H., & Lu, X. (2018). The beta-hydroxybutyrate suppresses the migration of glioma cells by inhibition of NLRP3 inflammasome. Cellular and Molecular Neurobiology, 38, 1479–1489.
- Sharifi-Rad, J., Rayess, Y. E., Rizk, A. A., Sadaka, C., Zgheib, R., Zam, W., Sestito, S., Rapposelli, S., Neffe-Skocińska, K., Zielińska, D., Salehi, B., Setzer, W. N., Dosoky, N. S., Taheri, Y., El Beyrouthy, M., Martorell, M., Ostrander, E. A., Suleria, H. A. R., Cho, W. C., … Martins, N. (2020). Turmeric and its major compound curcumin on health: Bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Frontiers in Pharmacology, 11, 01021.
- Shi, Z., Li, Y., Qian, X., Hu, Y., Liu, J., Zhang, S., & Zhang, J. (2017). MiR-340 inhibits triple-negative breast cancer progression by reversing EZH2 mediated miRNAs dysregulated expressions. Journal of Cancer, 8, 3037.
- Sintara, K., Thong-Ngam, D., Patumraj, S., & Klaikeaw, N. (2012). Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats. Journal of Biomedicine & Biotechnology, 2012, 915380.
- Song, W., Muthana, M., Mukherjee, J., Falconer, R. J., Biggs, C. A., & Zhao, X. (2017). Magnetic-silk core–shell nanoparticles as potential carriers for targeted delivery of curcumin into human breast cancer cells. ACS Biomaterials Science & Engineering, 3, 1027–1038.
- Spencer, L., Mann, C., Metcalfe, M., Webb, M., Pollard, C., Spencer, D., Berry, D., Steward, W., & Dennison, A. (2009). The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. European Journal of Cancer, 45, 2077–2086.
- Sun, Z.-J., Chen, G., Zhang, W., Hu, X., Liu, Y., Zhou, Q., Zhu, L.-X., & Zhao, Y.-F. (2011). Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma. Molecular Pharmacology, 79, 106–118.
- Sunwoo, Y.-Y., Lee, J.-H., Jung, H. Y., Jung, Y. J., Park, M.-S., Chung, Y.-A., Maeng, L.-S., Han, Y.-M., Shin, H. S., & Lee, J. (2015). Oldenlandia diffusa promotes antiproliferative and apoptotic effects in a rat hepatocellular carcinoma with liver cirrhosis. Evidence-based Complementary and Alternative Medicine, 2015, 501508.
- Talib, W. H., Mahmod, A. I., Kamal, A., Rashid, H. M., Alashqar, A., Khater, S., Jamal, D., & Waly, M. (2021). Ketogenic diet in cancer prevention and therapy: Molecular targets and therapeutic opportunities. Current Issues in Molecular Biology, 43, 558–589.
- Tamaddoni, A., Mohammadi, E., Sedaghat, F., Qujeq, D., & As'habi, A. (2020). The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway. Pharmacological Research, 156, 104798.
- Thangapazham, R. L., Puri, A., Tele, S., Blumenthal, R., & Maheshwari, R. K. (2008). Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. International Journal of Oncology, 32, 1119–1123.
- Tsujimoto, T., Kajio, H., & Sugiyama, T. (2017). Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population-based observational study. International Journal of Cancer, 141, 102–111.
- Veech, R. L. (2004). The therapeutic implications of ketone bodies: The effects of ketone bodies in pathological conditions: Ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 70, 309–319.
- Waly, M. I., Al-Bulushi, I. M., Al-Hinai, S., Guizani, N., Al-Malki, R. N., & Rahman, M. S. (2018). The protective effect of curcumin against nitrosamine-induced gastric oxidative stress in rats. Preventive Nutrition and Food Science, 23, 288–293.
- Wang, K., Qiu, Z.-. X., Wu, T.-. F., Chen, S.-. Z., Xiao, M., Huang, S.-. H., & Li, R.-. J. (2020). Ketogenic diet promotes apoptosis of tumor cells and inhibits tumor growth through inhibiting Wnt1/β-catenin signaling pathway in mouse xenograft models of human colon cancer. Research Square. https://doi.org/10.21203/rs.3.rs-58634/v1
10.21203/rs.3.rs?58634/v1 Google Scholar
- Weber, D. D., Aminazdeh-Gohari, S., & Kofler, B. (2018). Ketogenic diet in cancer therapy. Aging (Albany NY), 10, 164–165.
- Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020). Ketogenic diet in the treatment of cancer—Where do we stand? Molecular Metabolism, 33, 102–121.
- Werawatganon, D. (2017). Protective effects of curcumin on gastric inflammation and liver disease. In N. Shiomi & V. Waisundara (Eds.), Superfood and functional food-the development of superfoods and their roles as medicine. IntechOpen.
10.5772/66119 Google Scholar
- Wilder, R. M. (1921). The effects of ketonemia on the course of epilepsy. Mayo Clinic Proceedings, 2, 307–308.
- Wong, B. Y., Lau, B. H., Jia, T. Y., & Wan, C. P. (1996). Oldenlandia diffusa and Scutellaria barbata augment macrophage oxidative burst and inhibit tumor growth. Cancer Biotherapy & Radiopharmaceuticals, 11, 51–56.
- Woo, J. H., Kim, Y. H., Choi, Y. J., Kim, D. G., Lee, K. S., Bae, J. H., Min, D. S., Chang, J. S., Jeong, Y. J., Lee, Y. H., Park, J. W., & Kwon, T. K. (2003). Molecular mechanisms of curcumin-induced cytotoxicity: Induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis, 24, 1199–1208.
- Woolf, E. C., Curley, K. L., Liu, Q., Turner, G. H., Charlton, J. A., Preul, M. C., & Scheck, A. C. (2015). The ketogenic diet alters the hypoxic response and affects expression of proteins associated with angiogenesis, invasive potential and vascular permeability in a mouse glioma model. PLoS One, 10, e0130357.
- Wu, P. K., Tai, W. C. S., Liang, Z.-T., Zhao, Z.-Z., & Hsiao, W. L. W. (2009). Oleanolic acid isolated from Oldenlandia diffusa exhibits a unique growth inhibitory effect against ras-transformed fibroblasts. Life Sciences, 85, 113–121.
- Xiao, K., Jiang, J., Guan, C., Dong, C., Wang, G., Bai, L., Sun, J., Hu, C., & Bai, C. (2013). Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells. Journal of Pharmacological Sciences, 123, 102–109.
- Xu, M., & Mo, Y. Y. (2012). The Akt-associated microRNAs. Cellular and Molecular Life Sciences, 69(21), 3601–3612.
- Yadav, S. K., & Lee, S. C. (2006). Evidence for Oldenlandia diffusa-evoked cancer cell apoptosis through superoxide burst and caspase activation. Zhong Xi Yi Jie He Xue Bao, 4, 485–489.
- Yan, S., Jiang, H., Fang, S., Yin, F., Wang, Z., Jia, Y., Sun, X., Wu, S., Jiang, T., & Mao, A. (2015). MicroRNA-340 inhibits esophageal cancer cell growth and invasion by targeting phosphoserine aminotransferase 1. Cellular Physiology and Biochemistry, 37, 375–386.
- Yang, L., Liu, X., Lu, Z., Chan, J. Y.-W., Zhou, L., Fung, K.-P., Wu, P., & Wu, S. (2010). Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor. Cancer Letters, 298, 128–138.
- Yang, D., Li, Y., & Zhao, D. (2017). Curcumin induces apoptotic cell death in human pancreatic cancer cells via the miR-340/XIAP signaling pathway. Oncology Letters, 2, 1811–1816.
- Yin, G., Zhou, H., Xue, Y., Yao, B., & Zhao, W. (2016). MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2. Oncology Reports, 36, 1111–1118.
- Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'agostino, D., Planavsky, N., Lupfer, C., & Kanneganti, T. D. (2015). The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease. Nature Medicine, 21, 263–269.
- Yu, C., Li, W. B., Liu, J. B., Lu, J. W., & Feng, J. F. (2018). Autophagy: Novel applications of nonsteroidal anti-inflammatory drugs for primary cancer. Cancer Medicine, 7, 471–484.
- Yu, J., Wang, R., Chen, J., Wu, J., Dang, Z., Zhang, Q., & Li, B. (2017). miR-340 inhibits proliferation and induces apoptosis in gastric cancer cell line SGC-7901, possibly via the AKT pathway. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 23, 71.
- Yue, G. G.-L., Lee, J. K.-M., Kwok, H.-F., Cheng, L., Wong, E. C.-W., Jiang, L., Yu, H., Leung, H.-W., Wong, Y.-L., & Leung, P.-C. (2015). Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite. Scientific Reports, 5, 1–15.
- Zahra, A., Fath, M. A., Opat, E., Mapuskar, K. A., Bhatia, S. K., Ma, D. C., Rodman, S. N., III, Snyders, T. P., Chenard, C. A., Eichenberger-Gilmore, J. M., Bodeker, K. L., Ahmann, L., Smith, B. J., Vollstedt, S. A., Brown, H. A., Hejleh, T. A., Clamon, G. H., Berg, D. J., Szweda, L. I., … Allen, B. G. (2017). Consuming a ketogenic diet while receiving radiation and chemotherapy for locally advanced lung cancer and pancreatic cancer: The University of Iowa experience of two phase 1 clinical trials. Radiation Research, 187, 743–754.
- Zhang, L. L., Xie, F. J., Tang, C. H., Xu, W. R., Ding, X. S., & Liang, J. (2017). miR-340 suppresses tumor growth and enhances chemosensitivity of colorectal cancer by targeting RLIP76. European Review for Medical and Pharmacological Sciences, 21, 2875–2886.
- Zhang, N., Liu, C., Jin, L., Zhang, R., Wang, T., Wang, Q., Chen, J., Yang, F., Siebert, H.-C., & Zheng, X. (2020). Ketogenic diet elicits antitumor properties through inducing oxidative stress, inhibiting MMP-9 expression, and rebalancing M1/M2 tumor-associated macrophage phenotype in a mouse model of colon cancer. Journal of Agricultural and Food Chemistry, 68, 11182–11196.
- Zou, Y., Fineberg, S., Pearlman, A., Feinman, R. D., & Fine, E. J. (2020). The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer. PLoS One, 15, e0233662.